SK-Pharma company aim is to be a leading first to launch generic player in the market of interest, through strategic alliances, product development, licensing medicament and manufacturing of specialty pharmaceutical medicament. The company goal is to achieve 80% first to launch rates in the markets of operation. SK-Pharma is striving to improve and ensure their product portfolio and market of operations based on blue ocean strategy, where low competition and high growth is expected. The leading catalyst for success will always be laser focus on early launch opportunities in overall stable business environment. SK-Pharma invests and excels in building data science and smart machines capabilities that allows serving the group aims and objectives in agility.